SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-21-020181
Filing Date
2021-08-16
Accepted
2021-08-16 16:21:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 306386
2 ex5-1.htm EX-5.1 13190
3 ex23-1.htm EX-23.1 5498
4 ex23-2.htm EX-23.2 4049
5 ex5-1_001.jpg GRAPHIC 5806
6 ex5-1_002.jpg GRAPHIC 2905
7 ex23-1_001.jpg GRAPHIC 3828
  Complete submission text file 0001493152-21-020181.txt   347830
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258854 | Film No.: 211178567
SIC: 2834 Pharmaceutical Preparations